Bepotastine besilate
- Level
- Commodity
- Parent
- 51313200
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51313215This classification denotes a histamine-1 receptor antagonist with the molecular formula C21H25CLN2O3.C6H6O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6W18MO1QR3. European Medicines Agency schedules bepotastine besilate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05778MIG. The term bepotastine besilate is a Japanese Accepted Name designation. Most nations, for tariff and trade purposes, schedule bepotastine besilate under HS 29333999 and SITC 51574. As of Q4 2014, BEPOTASTINE BESILATE remains US FDA's Preferred Term for this commodity. Bepotastine besilate bears US NLM identifiers UMLS ID C1723019 and NCI Concept Code C83550. SMILES: C1CCC(CC1)S(=O)(=O)O.C1CCNC(C1)[C@H](C2CCC(CC2)CL)OC3CCN(CC3)CCCC(=O)O.
Same parent
Under 51313200 · 20Activities that produce or sell this
KBLI · 9Inherited from family 51310000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.